Goldline Pharmaceutical Ltd. IPO

Goldline Pharmaceutical Ltd. is listed in the SME segment. The figures below are as reported by the exchanges and public sources.

Goldline Pharmaceutical Ltd. IPO — key facts

• As of 6 September 2026, the Goldline Pharmaceutical Ltd. IPO subscription status is 840.74x overall.
• The issue is open from 12-May-2026 to 14-May-2026.
• Goldline Pharmaceutical Ltd. listed on 19-May-2026.
• Goldline Pharmaceutical Ltd. listed at ₹56.77. The listing gain was 32.0% against the upper end of the issue price band.

Goldline Pharmaceutical Ltd. IPO details

Status

Listed

Segment

SME

Sector

Pharmaceuticals

Price

₹43

Issue size

₹11.61 Cr

Fresh issue

₹11.02 Cr

Opens

12-May-2026

Closes

14-May-2026

Listing

19-May-2026

Total subscription

840.74x

Retail

881.15x

QIB

180.22x

NII

1662.04x

Lead managers

Cumulative Capital

Listing price

₹56.77

Listing day change

+32.0%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing
• Accretion Nutraveda Ltd. +48.2% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.